• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Thermo Fisher Invests $50M to Grow Biologics Footprint

    Q Therapeutics, REPROCELL Form MAGiQ Therapeutics

    Synpromics, Lonza Enter Partnership

    Noramco, SPI Pharma Sign Agreement

    Codexis, Porton Enter Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Thermo Fisher Invests $50M to Grow Biologics Footprint

    Codexis, Porton Enter Collaboration

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Welcomes Illinois Governor
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Q Therapeutics, REPROCELL Form MAGiQ Therapeutics

    Noramco, SPI Pharma Sign Agreement

    Codexis, Porton Enter Collaboration

    AMRI Expands NMR Spec Capabilities in Europe

    WuXi AppTec Opens Laboratory Testing Facility in NJ
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Avid Bioservices, Inc.

    Apex Graphics Inc.

    Adaptive Clinical Systems

    iuvo BioScience

    Exelead
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Harmonized Tariff Schedule Classification

    Importation of Organic Chemicals into the U.S.

    Related CONTENT
    • Risk Management in the Biomaterial Cold Chain
    • Confab C-TPAT Accredited
    • Combatting the Counterfeiters
    • Materials Sourcing
    • ACRO Testifies to U.S. ITC on India Policies
    Robert E. Schwartz01.23.12

    The Harmonized Tariff Schedule of the United States (HTSUS)1 classifies goods based on a variety of attributes, such as name, use or material in its makeup. The schedule consists of 99 chapters and a variety of appendices, and is used to assign the 10-digit numbers necessary to import compounds into the U.S.2 Organic chemicals are described in chapters 28-30 but mainly in chapter 29. HTSUS classification depends primarily on the structure of a compound, but is also affected by other characteristics such as its source or use. Major changes the international Harmonized System (HS) goods nomenclature, and the resultant changes in the HTSUS expected in early 2012, make a review of this topic especially timely.


    HTSUS Number
     

    In the U.S. the Harmonized Tariff Schedule classification is a 10-digit number as illustrated in Figure 1. The first six digits are internationally harmonized and consist of a chapter, heading, and subheading; the last four digits are U.S. specific, consisting of U.S. tariff rates and statistical reporting.
     

    Key Organizations 
     

    International

    The World Customs Organization (WCO)3 is the intergovernmental organization responsible for maintaining the international Harmonized System (HS) goods nomenclature for the 206 participating nations.


    U.S.

    1. The U.S. International Trade Commission maintains and publishes the U.S. Harmonized Tariff Schedule.4
    2. The U.S. Customs Service is responsible for administering the HTSUS, including classification of imported goods, collecting duties, ruling on country of origin, enforcing requirements of other federal agencies, etc.5
    3. The U.S. Census Bureau compiles and reports trade data collected under HTSUS classifications and generates balance-of-trade statistics. It also maintains and publishes the Schedule B for Exports, the structure of which is also based on the international HS.6


    Types of Classification

     

    1. Chemical Classification: The HTSUS classification of organic chemicals in chapter 29 is based mainly on chemical structure. Simpler structures are provided for in the beginning of the chapter and increase in complexity as one moves through the headings. Note 3 to chapter 29 provides that chemicals that could be included in two or more headings (by virtue of their functional structure) are to be classified in the heading that comes last in numerical order. For example, sulfonamides would fall in heading 2935, which comes later in the chapter than other functionalities.
    2. Chemical Appendix: The Chemical Appendix is a list of compounds that were imported into the U.S. before January 1, 1978, or were produced in the U.S. before May 1, 1978. It consists of approximately 10,000 compounds listed by Chemical Abstracts (CAS) registry number where known, or the common chemical name or trade name where the CAS number is not available. This appendix was originally created to make tariff rate distinctions that have since disappeared through multilateral negotiations; differences in duty treatment, if any, at this point, would be in the column 1-special duty rate column. Despite this, accurate HTSUS classification requires consideration of this appendix.7
    3. Named Compounds: There are approximately 1,200 compounds specified by name in the current HTSUS. For example, methyl ethyl ketone (Figure 2) is a named compound in subheading 2914.12.0000.
    4. Pharmaceutical Appendix: The Pharmaceutical Appendix consists of approximately 7,500 products found in International Non-proprietary Names (INN), as well as their named derivatives.8 Compounds on this appendix are eligible for duty-free entry under General Note 13 to the tariff schedule, but presence on the list d oes not affect their HTSUS classification.
    5. Intermediate Chemicals for Dyes Appendix:  This appendix enumerates those intermediate chemicals for dyes which are eligible for duty-free treatment under the provisions of general note 14 of the tariff schedule.9


    Methods of

    Classification


    1. Manual Lookup: Internal personnel with a technical background (often chemists and/or former customs agents) can classify compounds by manually looking them up in the HTSUS. Alternatively, some brokers and consultants will provide classifications, via manual lookup, for chemicals as part of a larger HTSUS classification service. Some formal training is usually required to perform this function for chemical classification. 


    For organizations importing only a small number of compounds this can be a reasonably efficient method. In addition, with a static list of chemical imports it is relatively simple to set up a database — basically a lookup table of identifier versus HTSUS classification. 


    The advantages of manual lookup are the flexibility to consider all aspects of the assignment, including source and use, and not base the classification strictly on structure. The main problems with manual lookup are

    1. the lack of efficiency (making it problematic to classify very large numbers of compounds),
    2. the potential for inconsistent classifications between different chemists, but also by the same chemist at different times, and 
    3. the steep learning curve required to perform this function, which can be aggravated by the rapid turnover of personnel that many companies experience.


    2. Automated Lookup: Several companies have written their own in-house automated HTS classification applications. Accelrys’ Pipeline Pilot is the most popular software for these applications, while Chemcart has also been used. There is also at least one commercially available automated HTSUS application available. 

        Advantages of automated lookup are

    1. consistency of classification of a given compound,
    2. the speed that assignments can be performed and
    3. minimal or no chemistry background or training is required for use. Problems arise from basing the classifications strictly on structure.


    Resources

     

    1. U.S. Customs Service: Online filing of an electronic binding ruling request can be submitted to the National Commodity Specialist Division of the Office of Regulations and Rulings via an eRulings Template will result in a ruling within 30 days of receipt.10
    2. CROSS Customs Rulings Online Search System: CROSS is a searchable database of past binding rulings that can be retrieved based on simple or complex searches using keywords, including compound names, CAS numbers and HTSUS 10-digit numbers.11


    Updates

    1. WCO: Major changes in the World Customs Organization Harmonized Commodity Coding and Classification System (Harmonized System) occur every five years. The last major update was in 2007; the next update is scheduled for January 2012.12
    2. HTSUS: The Harmonized Tariff Schedule of the U.S. is updated periodically to reflect Congressional legislation, Presidential proclamations, and other government actions. In 2010 there were three published updates and in 2011 there were two updates. In practice the changes with regards to chemicals in chapters 28-30 are few, if any. Detecting any changes is more problematic than the actual number of changes. 
      On the other hand, as already mentioned above, major changes in the HTSUS (including Chapters 28-30) occur every five years to correspond with changes in the international Harmonized System of the WCO.13, 14
    3. Appendices: The Pharmaceutical Appendix, which is a part of the HTSUS based on the International Non-proprietary Names, is a list of pharmaceuticals that is updated approximately every four years.15


    Evaluation and Summary


    Any organization that imports chemicals into the U.S., including big pharma, biotechs, chemical companies and CROs/CMOs, must classify compounds in the HTSUS system in order to get their compounds through U.S. Customs and pay the appropriate tariffs. Failure to meet a customs requirement can result in monetary fines (which can reach $100,000 per violation), as well as penalties ranging from seizing the merchandise to serving actual jail time.16 In practice, the federal government regards compliance with U.S. import requirements as a shared responsibility between U.S. Customs and industry. 


    Organizations with modest numbers of compounds or a static list of compounds to import can use manual lookup with a reasonable expectancy that they will be compliant, and if not, that minor corrections will not result in fines.


    Larger numbers of compounds can be very problematic. Imports consisting of several hundred to tens of thousands of new compounds can be a challenge. It is impractical to expect U.S. Customs to produce binding rulings for more than a handful of compounds, and a 30-day turnaround (although, in practice rulings are often faster than that) does not lend itself to today’s fast pace for international trade. Likewise, manual lookup is also impractical for large numbers of samples unless they are relatively homogenous, say, small variations on a structural theme. 


    The only practical way to deal with large numbers of diverse compounds is to use automated methods, which are based solely on the structure of the molecule being classified. Although disregarding non-structural information can be seen as a disadvantage, in practice manual lookup (like automated lookup) is usually based primarily, if not solely, on structure. 
     

    Coupling disclaimers with automated methods allows selected human interaction to modify classifications when pertinent, non-structural information is available. For example, Ribavirin (Figure 3) could be classified as 2934.99.9000 based on chemical classification, which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Other: Other: Other” and a disclaimer for this classification would state “Unless ‘Drugs, then HTS - 2934.99.4700”. An end-user who is aware that Ribavirin is a “Drug” (or can look up the binding ruling) would know that the disclaimer applies. If they are only aware of the structure it is unlikely they would make this distinction.


    A variety of different methods are being utilized to perform the function of classifying chemicals in the HTSUS system for import into the U.S. The complexity of the schedule virtually guarantees that no organization will be 100% compliant. Likewise, U.S. Cus-toms has neither the tools nor the resources to comprehensively monitor all chemicals coming into the U.S. for HTSUS compliance. Being able to document due diligence is probably the best an organization can do to deal with this complex task and minimize risk of non-compliance.  

     

    References

    1. www.usitc.gov/publications/docs/tata/hts/bychapter/
    2. en.wikipedia.org/wiki/Harmonized_Tariff_Schedule_for_ the_United_States
    3. en.wikipedia.org/wiki/World_Customs_Organization
    4. www.usitc.gov/
    5. www.cbp.gov/xp/cgov/trade/
    6. www.census.gov/
    7. www.usitc.gov/publications/docs/tata/hts/bychapter/0900CHEMAPPX.pdf
    8. www.who.int/medicines/services/inn/en/ 
    9. www.usitc.gov/publications/docs/tata/hts/bychapter/1100DYESAPPX.pdf
    10. www.cbp.gov/xp/cgov/trade/legal/rulings/eRuling Requirements.xml
    11. rulings.cbp.gov/
    12. info.managementdynamics.com/rs/managementdynamics/images/WCO%202012%20Delta%20Report.pdf?mkt_tok=3RkMMJWWfF9wsRokvq3KZKXonjHpfsX74%2BorWKCg38431UFwdcjKPmjr1YEASMB0dvycMRAVFZl5nQFZFOGSeY1F9OFZEk%2BzVTL8kw%3D%3D
    13. www.wcoomd.org/files/1.%20Public%20files/PDFand Documents/HarmonizedSystem/HS%20Overview/NG0163B1.pdf
    14. www.usitc.gov/tariff_affairs/hts_documents/1205-7 FinalReport.pdf
    15. www.usitc.gov/tariff_affairs/hts_documents/pub4208.pdf
    16. www.fuerstlaw.com/practice-areas/customs-fines-and-penalties

     

    Robert E. Schwartz was a scientist at Merck & Co. for 26 years and is one of the recipients of the ACS 2006 Heroes of Chemistry awards for the discovery of Cancidas. He is presently the owner of MyIslandBeach LLC (www.myislandbeach.net/) and can be contacted at schwart@optonline.net.

    Related Searches
    • Chemistry
    • Pharma
    Suggested For You
    Envigo Launches Hepatotoxicity Testing Envigo Launches Hepatotoxicity Testing
    Velesco Expands Materials Management Capabilities Velesco Expands Materials Management Capabilities
    Top 25 Pharma and Biopharma Report Top 25 Pharma and Biopharma Report
    BioStem Begins Construction of New Lab BioStem Begins Construction of New Lab
    The Top 25 Report The Top 25 Report
    Top 25 Pharma and Biopharma Report Top 25 Pharma and Biopharma Report
    Selcia Opens New API Facility Selcia Opens New API Facility
    ACRO Testifies to U.S. ITC on India Policies ACRO Testifies to U.S. ITC on India Policies
    Materials Sourcing Materials Sourcing
    Combatting the Counterfeiters Combatting the Counterfeiters
    Confab C-TPAT Accredited Confab C-TPAT Accredited
    Risk Management in the Biomaterial Cold Chain Risk Management in the Biomaterial Cold Chain

    Related Features

    • Know Your Drug:  A Solution to Dissolution

      Know Your Drug: A Solution to Dissolution

      Examining key strategies for solubility and dissolution assessment of new drug products, drug product intermediates and APIs
      Luís Sousa, Mafalda Paiva and Pedro Serôdio, Hovione 03.07.17

    • APIs | Cleaning Validation | Validation
      Limiting APIs in Manufacturing Effluent

      Limiting APIs in Manufacturing Effluent

      An approach for setting limits on pharmaceuticals discharged in manufacturing effluent
      Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc. 06.02.16

    • Process Development | Supply Chain
      Biopharma CMO Market Trends

      Biopharma CMO Market Trends

      Continued strong growth in biopharma industry is being driven by biosimilars
      Tim Wright, Editor 06.02.16


    • cGMP Manufacture | Excipients | Process Development | Supply Chain
      Continuous Pharmaceutical Processes and Their Demands

      Continuous Pharmaceutical Processes and Their Demands

      A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.
      Girish Malhotra, EPCOT International 04.05.16

    • Capsules | Extractables and Leachables | Fill/Finish | Supply Chain

      Newsmakers: Hanns-Christian Mahler

      Head of drug product services talks about Lonza’s new capabilities
      Tim Wright, Editor 03.09.16

    • APIs | Industry News | Injectables | Process Development
      Consolidation in Outsourcing

      Consolidation in Outsourcing

      Reviewing 2015’s M&A activity
      Michael A. Martorelli, Fairmount Partners 03.09.16


    • Process Development | QA/QC | Supply Chain | Validation
      Contract Manufacturing: Setting Standards in the Supplement Industry

      Contract Manufacturing: Setting Standards in the Supplement Industry

      Ensuring nutraceuticals are produced safely and according to strict quality requirements is paramount in the current climate of regulatory scrutiny.
      Sean Moloughney, Nutraceuticals World 03.09.16

    • APIs | Capsules | Excipients | Serialization | Supply Chain
      Solid Dosage Outsourcing Trends

      Solid Dosage Outsourcing Trends

      The market continues to evolve as blockbusters are replaced by more targeted treatments that have unique requirements.
      Tim Wright, Editor 03.09.16

    • APIs | Capsules | Excipients | Process Development | Validation
      Liquid Fill Hard Capsule Technology

      Liquid Fill Hard Capsule Technology

      A simple and versatile tool for new compounds and life cycle management
      Stephen Brown and Wei Tian, Encap Drug Delivery 03.09.16


    • APIs | Logistics
      Pharmaceutical Life Cycle Management

      Pharmaceutical Life Cycle Management

      Today’s competitive landscape requires new strategies
      Marko Salo, Fermion Oy 11.17.15

    • Four Pillars to Guide Your CRO Search

      Four Pillars to Guide Your CRO Search

      Tips on how to seek out the best possible CRO-Sponsor relationship
      Alan Findlater , WIL Research 11.17.15

    • Process Development | Regulatory Affairs

      Differentiate By Being Specific

      Why nimble niche CMOs may be a better choice
      Paul Shields and Angelo P. Consalvo, Enteris BioPharma 10.07.15

    • Validation
      Partnering with CROs to Develop High-Quality ADCs Key Bioanalytical Strategies

      Partnering with CROs to Develop High-Quality ADCs Key Bioanalytical Strategies

      ADCs are a breakthrough cancer treatment that can deliver cytotoxins directly to cancer cells without the sweeping collateral damage of traditional chemotherapy.
      Franklin Spriggs, Stephanie Mowery and Bo Kowalcyk, AIT Bioscience 10.07.15

    • APIs | Cleaning Validation | Validation
      Deriving Health-Based Exposure Limits in the Pharmaceutical Industry

      Deriving Health-Based Exposure Limits in the Pharmaceutical Industry

      A workshop was convened to advance harmonization and best practices in ADE/PDE derivation and application
      09.11.15

    • APIs | Capsules | Excipients | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Process Development | Process Validation | QA/QC | Solid Dosage/Semi-solids | Supply Chain | Validation
      Continuous Process in Pharmaceutical Manufacturing: Considerations, Nuances and Challenges

      Continuous Process in Pharmaceutical Manufacturing: Considerations, Nuances and Challenges

      A review of the business and process considerations for continuous processing in pharma manufacturing
      Girish Malhotra, EPCOT International 06.02.15

    Breaking News
    • Thermo Fisher Invests $50M to Grow Biologics Footprint
    • Q Therapeutics, REPROCELL Form MAGiQ Therapeutics
    • Synpromics, Lonza Enter Partnership
    • Noramco, SPI Pharma Sign Agreement
    • Codexis, Porton Enter Collaboration
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.